EUVIMEDEUVIMED entdecken
Crossref

Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework

Sridhar Mangalesh, Sharanya Kaushik, Raiza Rossi, Armin Nouri, Shefa Arya Nezhad, Abdulla A. Damluji, Michael G. Nanna

JAMA Network Open · 19.11.2026 · 9 (11) · e2646419

DOI: 10.1001/jamanetworkopen.2026.46419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 19.11.2026. Verfasst von Sridhar Mangalesh und 6 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cross-sectional study estimates eligibility for low-dose aspirin for primary prevention based on updated Predicting Risk of Cardiovascular Disease Events risk thresholds.

Zitieren

APA

Mangalesh, S., Kaushik, S., Rossi, R., Nouri, A., Nezhad, S. A., Damluji, A. A., & Nanna, M. G. (2026). Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework. JAMA Network Open, 9(11), e2646419. https://doi.org/10.1001/jamanetworkopen.2026.46419

Vancouver

Mangalesh S, Kaushik S, Rossi R, Nouri A, Nezhad SA, Damluji AA, et al. Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework. JAMA Network Open. 2026;9(11):e2646419. doi:10.1001/jamanetworkopen.2026.46419

BibTeX
@article{Mangalesh2026,
  author = {Mangalesh, Sridhar and Kaushik, Sharanya and Rossi, Raiza and Nouri, Armin and Nezhad, Shefa Arya and Damluji, Abdulla A. and Nanna, Michael G.},
  title = {Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {11},
  pages = {e2646419},
  doi = {10.1001/jamanetworkopen.2026.46419}
}
Kostenlos starten →